Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$7,759,549
-$897,974 QoQ
Shares Held
61,418
-1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#480
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED BANK holds $40,489,174 across 8 Drug Manufacturers - General names. GILD ranks #3 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
54,544 | $13,852,538 | |
| 2 | AMGN |
Amgen Inc
|
34,754 | $12,585,118 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
61,418 | $7,759,549 | |
| 4 | LLY |
ELI LILLY & Co
|
1,751 | $2,100,202 | |
| 5 | ABBV |
AbbVie Inc.
|
6,081 | $1,530,222 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,248 | $1,051,448 | |
| 7 | PFE |
Pfizer Inc
|
42,568 | $1,025,037 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,553 | $585,060 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,759,549 | 61,418 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $8,657,523 | 62,119 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,959,074 | 64,845 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,695,518 | 78,338 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $9,222,720 | 83,185 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $8,551,542 | 76,319 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||